当前位置: 首页 > 期刊 > 《云南中医中药杂志》 > 2019年第7期
编号:13367863
茯苓导水汤联合激素加环磷酰胺治疗膜性肾病临床观察(1)
http://www.100md.com 2019年7月1日 《云南中医中药杂志》 2019年第7期
     摘要:目的 探寻茯苓导水汤联合激素加环磷酰胺治疗膜性肾病临床疗效。方法 选取2017年9月—2019年2月辽宁中医药大学附属医院肾内科经肾活检或PLA2R检测证实的成人膜性肾病患者38例,对照组患者采用激素联合环磷酰胺治疗,治疗组患者采用茯苓导水汤联合激素加环磷酰胺治疗,治疗6个月后,比较患者的临床症状改善情况、24 h尿蛋白定量、血浆白蛋白及有效率。结果 化验指标及中医证候积分在治疗前2组差异无统计学意义(P>0.05),经过分组治疗后治疗组患者化验指标及中医证候的改善情况更加明显(P<0.05)。结论 茯苓导水汤联合激素加环磷酰胺治疗膜性肾病效果较好。

    关键词:茯苓导水汤;膜性肾病;激素;环磷酰胺

    中图分类号:R692 文献标志码:B 文章编号:1007-2349(2019)07-0031-03

    【Abstract】Objective:To study the clinical effect of Poria Cocos Decoction combined with hormone plus cyclophosphamide on the treatment of membranous nephropathy. Methods: 38 patients with adult membranous nephropathy who were confirmed by renal biopsy or PLA2R in the Department of Nephrology in The Affiliated Hospital of Liaoning University of Traditional Chinese Medicine from September 2017 to February 1919 were selected and divided into a western medicine group and a Chinese and Western medicine group. The western medicine group was treated with hormone combined with cyclophosphamide and the Chinese and western medicine group were treated with Poria Cocos Decoction combined hormone with cyclophosphamide. After 6-month treatment ......
1 2 3下一页

您现在查看是摘要页,全文长 3436 字符